ISPO

Prognostic Markers

Prognostic parameters in endometrial carcinoma and hyperplasia

Bengt Lindahl MD, PhD, Roger Willen MD, PhD

Prognostic value of different parameters of dna distribution in invasive breast cancer

G Nicolo, E Margallo, M Margiocco, GB Oliveri, A Belcastro, S Toms, L Santi

Diagnostic and therapeutic aspects of systematic lymphadenectomy in gastric carcinoma

J Jahne, MD, HJ Meyer, MD, R Pichlmayr, MD, FACS

Prognostic significance of lymph node in rectal carcinoma

O Dworak MD, PhD, A Altendorf-Hofmann MD, PhD, U Mansmann PhD

The value of metallothionein as a prognostic marker in human cancer

KW Schmid, B Dockhorn-Dworniczak, ME Elmes, B Jasani

Predictive value of neuron-specific enolase, tissue polypeptide antigen and carcinoembryonic antigen determination in lung cancer patients under chemotherapeutic treatment

E Soresi, A Noseda, G Invernizzi, R Boffi, A Scanni, S Cobelli, A Spinazzi

C-myc protein distribution: neoplastic tissues of the human colon

N Tulchin PhD, L Ornstein PhD, N Harpaz PhD MD, J Guillem MD+, K O'Toole MD, C Borner PhD#

Pretherapeutical cluster-5 anti-idiotype specific antibody reactivity in sera of patients with small cell lung cancer relationship to the clinical outcome

Hans-Peter Lehmann, Jean J Body, Marianne Paesmans, Uwe Zangemeister-Wittke, R Waibel, RA Stahel

Season of tumor detection influences the prognosis of breast cancer in japanese women

Y Nakamura, T Shirasaka, H Watanabe, M Kawaguchi, F Koba, N Karimine, R Abe, K Mayumi

Amplification of the HER-2 oncogene in endometrial hyperplasia and microinvasive carcinoma

KF Czerwenka MD, R Zeillinger PhD, JW Hosmann MD, M Manavi MD, Y Lu MD, E Kubista MD

Estrogen receptor(ER) in metastatic breast cancer tumors as a most important prognostic factor of longer survival

Y Nomura, H Tashiro, K Hisamatsu, M Baba

Cell-mediated immunity (CMI) in the post-operative follow-up of non relapsed breast cancer patients

A Nicolini, R Spinelli, P Ferrari, G Meucci, L Giuliani

DNA flow cytometry: a predictor of highly risky group in cervical cancer

M Anton, R Nenutil, A Rejthar, J Kopecny, J Zaloudik, B Ptackova

Carcinoembryonic antigen levels of peripheral and draining venous blood in patients with non-small cell lung cancer

J Niklifiski, M Furman, J Moniuszko-Jakoniuk, J Laudafiski, W Kedzierska

Prostatic acid phosphatase, prostate-specific antigen and B-microseminoprotein immunoreactivity as prognostic indicators of prostatic carcinoma

H Sakai MD, Y Yogi MD, H Hyakutake MD, Y Minami MD, H Kanetake MD, Y Saito MD

Prostatic adenocarcinoma therapeutical influence in circulating lymphocytic subpopulations

F Madeira Pina, J Candeias, PD Oliveira, J Andrade, H Barros, M Reis

Usefulness of coagulation markers in staging, and prognostic evaluation of gastric cancer

V Abbasciano, S Sartori, D Tassinari, I Nielsen, L Trevisani, D Arcudi, G Cavallesco

Endosonographic diagnosis of peritoneal carcinomatosis with transrectal scan

T Kajiyama MD, K Hajiro MD, F Kusumi MD, S Ueda MD, M Okuma MD, M Sakai MD, K Inoue MD

IGD myeloma: clinical characteristics and a new staging system based on analysis of japanese patients

Y Shimamoto, MD